Infliximab then Efalizumab, the ‘Hit and Run’ Approach Does Not Work

Publisher: Karger

E-ISSN: 1421-9832|216|2|171-172

ISSN: 1018-8665

Source: Dermatology, Vol.216, Iss.2, 2008-01, pp. : 171-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract